Hypertension and Dyslipidemia in Type 2 Diabetes Mellitus in United Arab Emirates

Abstract

BackgroundIn United Arab Emirates (UAE), the prevalence of Diabetes Mellitus was 19.6% in 1998-2000. Co-morbidity with Hypertension (HT) and Dyslipidemia (DL) increases the probability of cardiovascular complications, and hence the study of the distribution of HT and DL in patients with type 2 Diabetes Mellitus (DM) and their control. MethodSource of data was the records of one private and one government hospital in Northern Emirates, UAE. 294 patients with type-2 DM, who attended the hospitals from September to November, 2009 were included. A checklist was used for collection of data. Relevant data were collected from the records, entered on Microsoft Excel spreadsheet and analyzed using PASW 17.0 statistics. Proportions and Chi-square tests were used for assessing the co-morbidity of HT and DL, and control of DM with respect to socio-demographic variables. ResultsOf the total type 2 DM patients, 50.7% were males, 95% married, 76.5% of Middle East origin and only 12.6% were paying patients. The most common (49%) age group was 40-59 years. 8.6% of the type 2 DM patients did not have HT or DL or, 69.6% had DL, 88% had HT, and 66.1% had both. There was a statistically significant (p<0.05) association between age and DL and nationality and DL, but not with HT. Duration of HT and DL were similar to that of type 2 DM.Only 32% had type 2 DM under control. As for control of DL, 60.2% had triglyceride under control, 59.5% LDL and 7.4% HDL. 39.3% had systolic and 52.7% diastolic blood pressure under control. ConclusionCo-morbidity with HT and DL is found to be high in the patients with type-2 DM. The poor control of all three conditions highlights the importance of all levels of prevention to reduce the risk of cardiovascular complications.

A Current Status of Diabetes Mellitus in India: A Review

“…[35,36] The United Kingdom government places special emphasis on diabetes care in patients, with the National Health Service conducting various patient education programs and trials to improve quality of life of patients such as the "Dose Adjustment for Normal Eating" (DAFNE) study and "Diabetes Education & Self-Management for Ongoing & Newly Diagnosed" (DESMOND) study to provide patient education. [37] Similarly, a government initiative in the United Arab Emirates has set up an expert panel to form guidelines for diabetes management and public awareness programmes. [38] This has resulted in positive health effects which may arrest rising trend in …”

Assessment of Antidiabetic Potencial of Leucas Cephalotes Spreng Extract in Alloxan Induced Laboratory Animals

“…The leaves are used combination with other drugs are to treat scorpion bite but they are not being used to prepare the chemical constituent antidote to scorpion venom. The plant is also used in piles and malaria 6 .…”